ClinicalTrials.gg
Drug

Metoclopramide clinical trials

Also written Reglan.

studies test it
96
open now
12
in phase 3
21
first study started
1996

How each study uses Metoclopramide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Metoclopramide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Feb 1979 · REGLAN · NDA 017862 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Metoclopramide
59
Metoclopramide 10mg
11
Primperan
4
Plasil
4
Metoclopramide (Maxolon)
4

Brand

Reglan
14
Maxolon
1

Development codes

EVK-001
1

Studies by the year they started

95 studies that test it; most in 2009 (6)

Studies that test Metoclopramide, by start year
YearStudies
19962
20021
20041
20053
20065
20074
20084
20096
20103
20112
20125
20134
20146
20153
20164
20175
20183
20195
20201
20216
20226
20234
20243
20255
20264

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
16
Phase 3
21
Phase 4
32
No phase
25

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 91

Montefiore Medical Center (8) · Ain Shams University (4) · Evoke Pharma (3) · Cairo University (2) · Tanta University (2) · Duke University (2) · Vanderbilt University (2) · Pamukkale University (2)

Often tested with

Tested in the same studies.

Ondansetron (10) · Dexamethasone (8) · Granisetron (4) · Propofol (4) · Diphenhydramine (4) · Erythromycin (3) · Ketorolac (3) · Acetaminophen (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Metoclopramide is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 4

Studies that test Metoclopramide.

Studies

Open first, then newest update. How each study uses Metoclopramide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 96

See all 96 studies that test Metoclopramide →

Given beside what is tested · 14 — Metoclopramide is usual care or a partner of the new treatment
As the comparator · 23 — what is tested is compared with Metoclopramide

Showing 20 of 23.

Codes

What other systems call Metoclopramide · ClinicalTrials.gg INT007825

  • MeSH (NLM) D008787MetoclopramideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L4YEB44I46METOCLOPRAMIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 6915Confirmed FDA, Wikidata
  • Wikidata Q421095metoclopramideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62046MetoclopramideOne source FDA
  • DrugBank DB01233One source Wikidata

Also registered as metoclopramide dihydrochloride (UNII 5YNA80E9TO · RxNorm 267035) and metoclopramide hydrochloride (UNII W1792A2RVD · RxNorm 267036).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.